Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
PharmaTher Holdings Ltd ( (TSE:PHRM) ) has issued an announcement.
PharmaTher Holdings has introduced PatchPrint, an automated tabletop 3D printer for microneedle patches, and filed a provisional U.S. patent for the system. The company aims to evolve from a product-focused developer into a broader microneedle patch platform provider spanning manufacturing systems, proprietary products and strategic partnerships.
PatchPrint is designed as a compact end-to-end patch production system that integrates dispensing, vacuum loading, accelerated drying, demolding and packaging for a wide range of drug and wellness payloads. PharmaTher expects the platform to support its existing PharmaPatch programs and enable deployment in settings such as pharmaceutical companies, hospitals, compounding pharmacies and remote locations for therapeutics, vaccines and other applications.
By extending its technology into manufacturing infrastructure, PharmaTher seeks to position itself as a differentiated partner for companies pursuing scalable, user-friendly and on-demand microneedle patch solutions. The commercialization strategy, including discussions with a medical-focused 3D printer manufacturer, signals a shift toward revenue opportunities in production services and collaborative product development across therapeutics, wellness, diagnostics, defense and humanitarian uses.
The most recent analyst rating on (TSE:PHRM) stock is a Hold with a C$0.07 price target. To see the full list of analyst forecasts on PharmaTher Holdings Ltd stock, see the TSE:PHRM Stock Forecast page.
Spark’s Take on PHRM Stock
According to Spark, TipRanks’ AI Analyst, PHRM is a Neutral.
The score is primarily pressured by weak financial fundamentals (pre-revenue operations, ongoing losses, negative cash flow, and eroding equity) despite improving burn rate and zero reported debt. Technicals also weigh on the score as the stock remains in a broader downtrend. Valuation is limited by negative earnings and no dividend support.
To see Spark’s full report on PHRM stock, click here.
More about PharmaTher Holdings Ltd
PharmaTher Holdings Ltd. is a specialty pharmaceutical company focused on microneedle patch drug delivery technologies. Its programs center on the PharmaPatch platform, targeting applications such as ketamine, psychedelic compounds, GLP-1 therapies and therapeutic peptides, with an emerging emphasis on customizable, on-demand transdermal solutions.
Average Trading Volume: 72,334
Technical Sentiment Signal: Sell
Current Market Cap: C$6.37M
See more data about PHRM stock on TipRanks’ Stock Analysis page.